1. Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation.
- Author
-
Ahmed, Raheel, Jamil, Yumna, Ramphul, Kamleshun, Mactaggart, Sebastian, Bilal, Maham, Singh Dulay, Mansimran, Shi, Rui, Azzu, Alessia, Okafor, Joseph, Memon, Rahat A, Sakthivel, Hemamalini, Khattar, Rajdeep, Wells, Athol Umfrey, Baksi, John Arun, Wechalekar, Kshama, Kouranos, Vasilis, Chahal, Anwar, and Sharma, Rakesh
- Subjects
SARCOIDOSIS treatment ,TREATMENT of cardiomyopathies ,HOSPITAL charges ,SEX distribution ,HOSPITAL care ,MAJOR adverse cardiovascular events ,QUESTIONNAIRES ,SARCOIDOSIS ,RETROSPECTIVE studies ,TREATMENT effectiveness ,DESCRIPTIVE statistics ,HOSPITAL mortality ,DISEASE prevalence ,ACUTE kidney failure ,ODDS ratio ,IMPLANTABLE cardioverter-defibrillators ,MEDICAL records ,ACQUISITION of data ,ATRIAL fibrillation ,CARDIAC arrest ,COMPARATIVE studies ,CONFIDENCE intervals ,LENGTH of stay in hospitals ,DISEASE incidence ,COMORBIDITY ,DISEASE risk factors - Abstract
Introduction: In patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation. Methods: The 2016–2020 National Inpatient Sample (NIS) database compared the characteristics and outcomes of males and females with CS receiving ICDs. Results: Among 760 CS patients who underwent inpatient ICD implantation, 66.4% were male. Males were younger (55.0 vs. 56.9 years, p <.01), had higher rates of diabetes (31.7% vs. 21.6%, p <.01) and chronic kidney disease (CKD) (16.8% vs. 7.8%, p <.01) but lower prevalence of atrial fibrillation (AF) (11.9% vs. 23.5%, p <.01), sick sinus syndrome (4.0% vs. 7.8%, p =.024), ventricular fibrillation (VF) (9.9% vs. 15.7%, p =.02), and black ancestry (31.9% vs. 58.0%, p <.01). Unadjusted major adverse cardiovascular events (MACE), defined as a composite of in‐hospital death, myocardial infarction (MI), and ischemic stroke, was higher in females (11.8% vs. 6.9%, p =.024), but when adjusted for age and tCharlson Comorbidity Index (CCI), females demonstrated significantly lower odds of experiencing MACE (aOR: 0.048, 95% CI: 0.006–0.395, p =.005). Incidence of acute kidney injury (AKI) post‐ICD was significantly lower in females (15.7% vs. 23.8%, p =.01) as was the adjusted odds (aOR: 0.282, 95% CI: 0.146–0.546, p <.01). There was comparable mean length of stay and hospital charges. Conclusion: ICD utilization in CS patients is more common among males, who have a higher prevalence of diabetes and CKD but a lower prevalence of AF, sick sinus syndrome, and VF. Adjusted MACE and AKI were significantly lower in females. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF